Implementing patient-reported health-related quality-of-life data in cancer routine practice to improve accuracy of prognosis. Are we there yet?

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 9, Issue 6, 2009, Pages 493-496

  Legrand, Catherine ^b   Efficace, Fabio ^a  

^a GIMEMA Data Centre   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADJUSTMENT; ADVANCED CANCER; CANCER PALLIATIVE THERAPY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL DECISION MAKING; CLINICAL PRACTICE; EDITORIAL; FACTORIAL ANALYSIS; HEALTH STATUS; MALIGNANT NEOPLASTIC DISEASE; OUTCOMES RESEARCH; PREDICTION; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SOCIAL INTERACTION; SURVIVAL TIME;

HEALTH STATUS; HUMANS; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; QUALITY OF LIFE; SURVIVAL RATE;

EID: 73549117430     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.09.59     Document Type: Editorial

References (25)

1. Glare P, Virik K, Jones M et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327(7408), 195-198 (2003).
2. Coates A, Gebski V, Signorini D et al. Prognostic value of quahty-of-life scores during chemotherapy for advanced breast cancer. J. Clin. Oncol. 10(12), 1833-1838 (1992).
3. Kramer JA, Curran D, Piccart M et al. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur. J. Cancer 36(12), 1498-1506 (2000).
4. Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D. Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur. J. Cancer 38(10), 1351-1357 (2002).
5. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 31(2-3), 233-240 (2001).
6. Chiarion-Sileni V, Del Bianco P, De Salvo GL et al. Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. Eur. J. Cancer 39(11), 1577-1585 (2003).
7. Dubois D, Dhawan R, van de Velde H et al. Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma. J. Clin. Oncol. 24(6), 976-982 (2006).
8. Blazeby JM, Brookes ST, Alderson D. The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut 49(2), 227-230 (2001).
9. Dancey J, Zee B, Osoba D et al. Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. Qual. Life Res. 6(2), 151-158 (1997).
10. Gotay CC, Kawamoto T, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. J. Clin. Oncol. 26(8), 1355-1363 (2008).
11. Quinten C, Coens C, Mauer M et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 10(9), 865-871 (2009).
12. Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY. Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 58(5), 1394-1404 (2004).
13. Fang FM, Liu YT, Tang Y, Wang CJ, Ko SF. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 100(2), 425-432 (2004).
14. Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J. Clin. Oncol. 14(1), 171-175 (1996).
15. Herndon JE, Fleishman S, Komblith AB, Kosty M, Green MR, Holland J. Is quality of life predictive of the survival of patients with advanced non small cell lung carcinoma? Cancer 85(2), 333-340 (1999).
16. Efficace F, Bottomley A, Smit EF et al. Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol. 17(11), 1698-1704 (2006).
17. Karvonen-Gutierrez CA, Ronis DL, Fowler KE, Terrell JE, Gruber SB, Duffy SA. Quality of life scores predict survival among patients with head and neck cancer. J. Clin. Oncol. 26(16), 2754-2760 (2008).
18. Mauer M, Bottomley A, Coens C, Gotay C. Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation. Expert Rev. Pharmacoeconomics Outcomes Res. 8(2), 179-196 (2008).
19. Slinker BK, Glantz SA. Multiple regression for physiological data analysis: the problem of multicollinearity. Am. J. Physiol. 249(1 Pt 2), R1-R12 (1985).
20. Van Steen K, Curran D, Kramer J et al. Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection. Stat. Med. 21(24), 3865-3884 (2002).
21. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat. Med. 11(16), 2093-2109 (1992).
22. Van Houwelingen HC. Validation, calibration, revision and combination of prognostic survival models. Stat. Med. 19 (24), 3401-3415 (2000).
23. Legrand C, Duchateau L, Janssen P, Ducrocq V, Sylvester R. Validation of prognostic indices using the frailty model. Lifetime Data Anal. 15(1), 59-78 (2009).
24. Efficace F, Bottomley A, Coens C et al. Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur. J. Cancer 42(1), 42-49 (2006).
25. Efficace F, Innominato PF, Bjarnason G et al. Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer. J. Clin. Oncol. 26(12), 2020-2026 (2008).